UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biological implications of polydimethylsiloxane-based microfluidic cell culture

Lab on a chip, 2009-01, Vol.9 (15), p.2132-2139

2009

Volltextzugriff (PDF)

Prolactin: The Third Hormone in Breast Cancer

Frontiers in endocrinology (Lausanne), 2022-06, Vol.13, p.910978-910978

2022

Volltextzugriff (PDF)

Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade

Nature communications, 2022-08, Vol.13 (1), p.4948-17, Article 4948

2022

Volltextzugriff (PDF)

Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells

PloS one, 2015-01, Vol.10 (1), p.e0116891

2015

Volltextzugriff (PDF)

Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers

Cancers, 2021-07, Vol.13 (15), p.3725

2021

Volltextzugriff (PDF)

Loss of BMAL1 in ovarian steroidogenic cells results in implantation failure in female mice

Proceedings of the National Academy of Sciences - PNAS, 2014-09, Vol.111 (39), p.14295-14300

2014

Volltextzugriff (PDF)

Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy

Breast cancer research : BCR, 2023-06, Vol.25 (1), p.68-68, Article 68

2023

Volltextzugriff (PDF)

Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action

Stem cell reports, 2017-10, Vol.9 (4), p.1167-1179

2017

Volltextzugriff (PDF)

PRL Activates the Cyclin D1 Promoter Via the Jak2/Stat Pathway

Molecular endocrinology (Baltimore, Md.), 2002-04, Vol.16 (4), p.774-784

2002

Volltextzugriff (PDF)

Bafilomycins produced by an endophytic actinomycete Streptomyces sp. YIM56209

Journal of antibiotics, 2011-01, Vol.64 (1), p.159-162

2011

Volltextzugriff (PDF)

Prolactin Enhances Insulin-like Growth Factor I Receptor Phosphorylation by Decreasing Its Association with the Tyrosine Phosphatase SHP-2 in MCF-7 Breast Cancer Cells

The Journal of biological chemistry, 2010-03, Vol.285 (11), p.8003-8012

2010

Volltextzugriff (PDF)

Stiff Collagen Matrices Increase Tumorigenic Prolactin Signaling in Breast Cancer Cells

The Journal of biological chemistry, 2013-05, Vol.288 (18), p.12722-12732

2013

Volltextzugriff (PDF)

Dynamic interactions between the extracellular matrix and estrogen activity in progression of ER+ breast cancer

Oncogene, 2019-10, Vol.38 (43), p.6913-6925

2019

Volltextzugriff (PDF)

Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells

Breast cancer research : BCR, 2017-01, Vol.19 (1), p.9-9, Article 9

2017

Volltextzugriff (PDF)

High collagen density augments mTOR-dependent cancer stem cells in ERα+ mammary carcinomas, and increases mTOR-independent lung metastases

Cancer letters, 2018-10, Vol.433, p.1-9

2018

Volltextzugriff (PDF)

Prolactin Does Not Require Insulin-Like Growth Factor Intermediates but Synergizes with Insulin-Like Growth Factor I in Human Breast Cancer Cells

Molecular cancer research, 2008-04, Vol.6 (4), p.634-643

2008

Volltextzugriff (PDF)

Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes

Journal of endocrinology, 2009-10, Vol.203 (1), p.99-110

2009

Volltextzugriff (PDF)

Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvement

Pharmacology & therapeutics (Oxford), 2016-09, Vol.165, p.79-92

2016

Volltextzugriff (PDF)

Prolactin synergizes with canonical Wnt signals to drive development of ER+ mammary tumors via activation of the Notch pathway

Cancer letters, 2021-04, Vol.503, p.231-239

2021

Volltextzugriff (PDF)

The Role of Prolactin in Mammary Carcinoma

Endocrine reviews, 2003-02, Vol.24 (1), p.1-27

2003

Volltextzugriff (PDF)

A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras Activation

Cell reports (Cambridge), 2019-08, Vol.28 (6), p.1526-1537.e4

2019

Volltextzugriff (PDF)

Inhibition of Prolactin (PRL)-Induced Proliferative Signals in Breast Cancer Cells by a Molecular Mimic of Phosphorylated PRL, S179D-PRL

Endocrinology (Philadelphia), 2003-12, Vol.144 (12), p.5300-5307

2003

Volltextzugriff (PDF)

Prolactin signaling through focal adhesion complexes is amplified by stiff extracellular matrices in breast cancer cells

Oncotarget, 2016-07, Vol.7 (30), p.48093-48106

2016

Volltextzugriff (PDF)

Modeling chemical effects on breast cancer: the importance of the microenvironment in vitro

Integrative biology (Cambridge), 2020-02, Vol.12 (2), p.21-33

2020

Volltextzugriff (PDF)

Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse

Advances in experimental medicine and biology, 2015-01, Vol.846, p.201

2015

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(142)

Publikationsform

Sprache

Englisch
(162)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(107)
Life Sciences & Biomedicine
(101)
Animals
(62)
Female
(61)
Humans
(57)
Biological And Medical Sciences
(35)
Endocrinology & Metabolism
(28)
Mice
(24)
Prolactin - Metabolism
(24)
Breast Cancer
(23)
Prolactin
(22)
Biochemistry & Molecular Biology
(21)
Cell Biology
(21)
Breast Neoplasms - Pathology
(20)
Fundamental And Applied Biological Sciences. Psychology
(20)
Oncology
(19)
Breast Neoplasms - Metabolism
(18)
Cell Line, Tumor
(18)
Tumors
(17)
Medical Sciences
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Biological implications of polydimethylsiloxane-based microfluidic cell culture

Prolactin: The Third Hormone in Breast Cancer

Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade

Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells

Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers

Loss of BMAL1 in ovarian steroidogenic cells results in implantation failure in female mice

Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy

Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action

PRL Activates the Cyclin D1 Promoter Via the Jak2/Stat Pathway

Bafilomycins produced by an endophytic actinomycete Streptomyces sp. YIM56209

Prolactin Enhances Insulin-like Growth Factor I Receptor Phosphorylation by Decreasing Its Association with the Tyrosine Phosphatase SHP-2 in MCF-7 Breast Cancer Cells

Stiff Collagen Matrices Increase Tumorigenic Prolactin Signaling in Breast Cancer Cells

Dynamic interactions between the extracellular matrix and estrogen activity in progression of ER+ breast cancer

Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells

High collagen density augments mTOR-dependent cancer stem cells in ERα+ mammary carcinomas, and increases mTOR-independent lung metastases

Prolactin Does Not Require Insulin-Like Growth Factor Intermediates but Synergizes with Insulin-Like Growth Factor I in Human Breast Cancer Cells

Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes

Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvement

Prolactin synergizes with canonical Wnt signals to drive development of ER+ mammary tumors via activation of the Notch pathway

The Role of Prolactin in Mammary Carcinoma

A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras Activation

Inhibition of Prolactin (PRL)-Induced Proliferative Signals in Breast Cancer Cells by a Molecular Mimic of Phosphorylated PRL, S179D-PRL

Prolactin signaling through focal adhesion complexes is amplified by stiff extracellular matrices in breast cancer cells

Modeling chemical effects on breast cancer: the importance of the microenvironment in vitro

Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse

Suchergebnisse filtern